Herpes zoster
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients clinically diagnosed with acute or subacute herpes zoster neuralgia; 2. Aged >= 18 years; 3. Unilateral involvement, with affected segments ranging from T1 to T4; 4. No prior paravertebral nerve block or other interventional therapy; 5. Agreed to participate in this study and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Thoracic anatomical abnormalities; 2. Patients with mental illness, comprehension disorders, or those unable to clearly express pain scores and cooperate with assessments; 3. Poorly controlled diabetes (e.g., fasting blood glucose >= 10.0 mmol/L); 4. Patients with severe cardiac, cerebral, hepatic, pulmonary, renal or other organ diseases, as well as hematological abnormalities; 5. Local or systemic infection at the puncture site, coagulation dysfunction, or other contraindications to relevant nerve blocks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Visual Analog Scale (VAS) Improvement; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Skin Temperature After Block;Changes in Pinprick Sensation After Block;Needle Insertion Time During Block;Improvement in VAS Score Compared to Baseline;Usage of Analgesic Medications;Evaluation of Sleep Quality Changes;Improvement in Anxiety and Depression;Success Rate of Block; | — |
Countries
China
Contacts
The First Affiliated Hospital of the Air Force Military Medical University